Literature DB >> 3742206

Recovery of function after brain damage: severe and chronic disruption by diazepam.

T Schallert, T D Hernandez, T M Barth.   

Abstract

Following unilateral damage to the anterior-medial region of the neocortex (AMC) in rats a sensory asymmetry appeared, but recovered within a week. In a separate group of rats with AMC lesions daily 3-week exposure to diazepam (Valium, 5 mg/kg) beginning 12 h after surgery caused recovery to be delayed indefinitely. The efficiency and speed (as opposed to symmetry) of behavior was not impaired. More than 9 weeks after discontinuation of diazepam (12 weeks postsurgery), recovery was still not apparent. Postmortem analysis ruled out lesion size as a contributing factor. In a second experiment undrugged animals with AMC lesions were allowed to recover for at least 3 weeks before being exposed to diazepam. These animals showed only a transient (2-day) reinstatement of asymmetry despite continuous drug treatment. We conclude that important mechanisms serving recovery of function may be vulnerable during a short period soon after brain damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742206     DOI: 10.1016/0006-8993(86)90261-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

Review 1.  Neurotransmitters and motor activity: effects on functional recovery after brain injury.

Authors:  Larry B Goldstein
Journal:  NeuroRx       Date:  2006-10

Review 2.  Behavioral tests for preclinical intervention assessment.

Authors:  Timothy Schallert
Journal:  NeuroRx       Date:  2006-10

3.  Amplification of acute focal ischemic deficit by narcotics.

Authors:  Jordan Dubow; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

4.  Proceedings of the British Pharmacological Society. 6th-8th January, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

Review 5.  Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation.

Authors:  Patricia B de la Tremblaye; Darik A O'Neil; Megan J LaPorte; Jeffrey P Cheng; Joshua A Beitchman; Theresa Currier Thomas; Corina O Bondi; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2017-05-30       Impact factor: 8.989

Review 6.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

7.  Biophysical Modeling Suggests Optimal Drug Combinations for Improving the Efficacy of GABA Agonists after Traumatic Brain Injuries.

Authors:  Shyam Kumar Sudhakar; Thomas J Choi; Omar J Ahmed
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

8.  The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study.

Authors:  Heidi M Schambra; Isis E Martinez-Hernandez; Kevin J Slane; Amelia K Boehme; Randolph S Marshall; Ronald M Lazar
Journal:  Restor Neurol Neurosci       Date:  2016-09-21       Impact factor: 2.406

9.  Acute neuroprotection to pilocarpine-induced seizures is not sustained after traumatic brain injury in the developing rat.

Authors:  G G Gurkoff; C C Giza; D Shin; S Auvin; R Sankar; D A Hovda
Journal:  Neuroscience       Date:  2009-08-18       Impact factor: 3.590

10.  Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome.

Authors:  X Cui; M Chopp; A Zacharek; J Dai; C Zhang; T Yan; R Ning; C Roberts; A Shehadah; N Kuzmin-Nichols; C D Sanberg; J Chen
Journal:  Neuroscience       Date:  2012-10-04       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.